BeStock  

GeneDx Holdings WGS

US equityMarket cap rank #2690Diagnostics & Research
$76.27 +$3.18 (+4.35%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $76.96 +0.91%
Open$73.35
Prev close$73.09
Day range$72.04 – $77.20
Volume855.2K
Market cap$2.27B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$427.54M+40.0% YoY
Operating profit-$13.08M+43.7% YoY
Net profit-$21.02M+59.8% YoY
Diluted EPS-$0.73+62.4% YoY
Free cash flow-$39.10M-585.6% YoY
Operating cash flow-$28.98M

Free cash flow by quarter

$-5.0MSep '24$-6.2MDec '24$4.1MMar '25$8.1MJun '25$9.6MSep '25$-7.4MDec '25$-38.9MMar '26$-39.1MJun '26

Annual revenue

$179.3MFY20$212.2MFY21$234.7MFY22$202.6MFY23$305.5MFY24$427.5MFY25

Profitability & balance sheet

Gross margin69.7%
Operating margin-3.1%
Net margin-4.9%

Cash flow

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Operating Cash Flow -$28.98M -$32.41M -$3.09M $15.77M $10.42M
-Change in Payables and Accrued Expense $602,000.00 -$13.17M $6.92M -$2.01M -$3.63M
-Change in Inventory -$5.66M $1.69M -$3.36M $1.33M $628,000.00
-Change in Receivables -$6.68M -$2.56M -$13.43M -$12.91M -$1.33M
Change in Working Capital -$22.64M -$23.16M $262,000.00 -$2.87M -$16.34M
Other Non-Cash Items -$921,000.00 $2.06M $438,000.00 $5.41M $4.37M
Deferred Tax -$518,000.00 $897,000.00 – $246,000.00 -$245,000.00
Depreciation & Depletion & Amortization $6.71M $6.81M $6.88M $6.47M $6.19M
Gain/Loss from Continuing Operations -$220,000.00 $4.03M – $3.40M -$2.18M
Net Income from Continuing Operations -$17.74M -$63.32M -$17.67M -$7.64M $10.81M
Net cash flow from continuing operations -$28.98M -$32.41M -$3.09M $15.77M $10.42M
Free Cash Flow -$39.10M -$38.86M -$7.44M $9.60M $8.05M
-Change In Other Working Capital -$10.90M -$9.13M $10.14M $10.72M -$12.01M
Net cash flow from investing -$5.63M -$17.26M -$11.07M -$4.69M -$36.35M
Beginning Cash Balance $94.92M $105.99M $96.96M $75.11M $100.69M
Net Change in Cash -$33.61M -$11.07M $9.03M $21.85M -$25.58M
Ending Cash Balance $61.31M $94.92M $105.99M $96.96M $75.11M
Proceeds from Stock Option Exercised $0.00 $58,000.00 $4.00M $182,000.00 $65,000.00
Net Common Stock Issuance -$95.21M $97.47M $19.87M $11.80M $1.13M
Net Issuance Payments Of Debt $96.21M -$58.94M -$682,000.00 -$1.22M -$853,000.00
Net Cash Flow from Continuing Financing Activities $1.01M $38.59M $23.19M $10.77M $346,000.00
Financing Cash Flow $1.01M $38.59M $23.19M $10.77M $346,000.00
Net Investment Purchase and Sale $4.48M -$10.80M -$7.06M $1.49M -$786,000.00
Net PPE Purchase and Sale -$10.11M -$6.45M -$4.35M -$6.17M -$2.37M
Net Cash Flow from Continuing Investing Activities -$5.63M -$17.26M -$11.07M -$4.69M -$36.35M
Net Business Purchase and Sale – – $339,000.00 $0.00 –

Income statement

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Other Income (Expense) -$5.52M -$26.38M -$7.61M -$139.86M $203.52M
Gain on Sale of Security -$1.20M -$13.37M $1.17M $70.23M $198.40M
Special Income (Charges) $0.00 $0.00 -$10.40M -$210.15M $0.00
-Less:Write Off $0.00 $0.00 $10.40M $210.15M $0.00
Other Non-Operating Income (Expenses) -$4.32M -$13.01M $1.62M $57,000.00 $5.11M
Pretax Profit -$21.14M -$52.63M -$176.69M -$598.03M -$245.39M
Tax -$116,000.00 -$343,000.00 -$926,000.00 -$49.05M $0.00
Profit from Continuing Operations -$21.02M -$52.29M -$175.77M -$548.98M -$245.39M
Net Income to Parent Company -$21.02M -$52.29M -$175.77M -$548.98M -$245.39M
Net Income to Common Stockholders -$21.02M -$52.29M -$175.77M -$548.98M -$245.39M
Total Other Finance Costs $2.54M $3.03M -$1.11M $666,000.00 –
Net Non-Operating Interest Income (Expense) -$2.54M -$3.03M $1.11M -$666,000.00 -$2.76M
Operating Profit -$13.08M -$23.21M -$170.19M -$457.51M -$446.15M
Basic EPS -$0.73 -$1.94 -$7.23 -$53.63 -$74.91
Net Profit -$21.02M -$52.29M -$175.77M -$548.98M -$245.39M
Total Revenue as Reported $427.54M $305.45M $202.57M $234.69M $212.20M
Total Operating Revenue $427.54M $305.45M $202.57M $234.69M $212.20M
Cost of Revenue $129.37M $111.05M $112.56M $261.44M $228.80M
Gross Profit $298.17M $194.40M $90.01M -$26.75M -$16.60M
Selling and Admin Expenses $239.22M $171.89M $199.98M $338.24M $318.73M
-Selling & Marketing Expense $88.41M $67.37M $60.96M $122.08M $112.74M
-General & Admin Expense $150.82M $104.52M $139.02M $216.17M $205.99M
Research & Development $72.03M $45.72M $58.27M $86.20M $105.16M
Operating Expense $311.25M $217.61M $260.20M $430.76M $429.55M
Diluted EPS -$0.73 -$1.94 -$7.23 -$53.63 -$74.91
Other Operating Expenses – – $1.96M $6.31M $5.66M
Non-Operating Interest Income – – – – $79,000.00
Non-Operating Interest Expense – – – – $2.84M

Discussion

No comments yet — be the first to weigh in on WGS.

Leave a comment

Scroll to Top